Blood test validation for breast cancer diagnosis
Part of Cancer, Skin clinical trials.
This study is testing a new blood test (liquid biopsy) to see if it can accurately detect breast cancer or track remission. If you are a woman getting a mammogram, have an abnormal finding, were recently diagnosed, or are in remission after treatment, you may be able to join and help validate this test.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 or older.
- You fit one of these groups: getting a routine mammogram (no history of breast cancer), had an abnormal mammogram or MRI (no breast cancer history), were just diagnosed with breast cancer (within 60 days and haven't started treatment), or had breast cancer before (stage 1-3) and are now in remission.
- You have not had a blood transfusion in the last 14 days.
- You have not had a heart attack, stroke, or pulmonary embolism in the last 3 months.
- You have not had an excisional breast biopsy (surgery to remove a lump) in the last 30 days. Needle biopsies are okay.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new blood test (liquid biopsy) that looks for tiny molecules called microRNAs to find early signs of breast cancer. It aims to detect cancer before symptoms appear, using a simple blood draw during your regular mammogram visit.
This study looks at a non-invasive blood test to detect cancer-related “signal patterns” and see how well they match different types of cancer. It may help researchers learn better ways to find or understand cancer using less invasive testing.
This study tests a new blood test that aims to find breast cancer early in women who are at higher risk or are going for routine screening. If you are a woman aged 30–75 and are scheduled for a mammogram, MRI, or breast ultrasound, you may be able to help validate this test.
This trial tests a blood test that looks for chemical changes in DNA to help diagnose breast cancer. It may offer a simpler way to detect cancer without needing a tissue sample.
This trial uses a special blood test to track cancer signals (called ctDNA) during and after treatment for early breast cancer. It aims to see whether monitoring these signals can help guide follow-up and treatment decisions.
This study looks at people who are being screened and just diagnosed with breast cancer and haven’t started treatment yet. It may help researchers understand how to better manage care from the start of treatment.
Hear when a new Breast Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.